Total Clarity Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-60
Closed -$8K 387
2021
Q4
$8K Hold
60
﹤0.01% 731
2021
Q3
$8K Buy
+60
New +$7.57K ﹤0.01% 727
2021
Q2
Sell
-88
Closed -$8K 327
2021
Q1
$8K Buy
+88
New +$8.26K ﹤0.01% 598

Other funds holding DXCM

Total Clarity Wealth Management's DXCM Position: Q1 2022 in Review

Total Clarity Wealth Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 60 shares — an estimated $8K sold.

Total Clarity Wealth Management first reported a position in DXCM in Q1 2021 and held it in 3 quarters. The position peaked at $8K in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Total Clarity Wealth Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 60 DexCom shares in Q1 2022, an estimated $8K.
  • Total Clarity Wealth Management first reported a position in DexCom in Q1 2021 and held it in 3 quarters.
  • Total Clarity Wealth Management's DexCom position peaked at $8K in Q4 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Total Clarity Wealth Management's 13F filing for Q1 2022, filed 29 Apr 2022.